Cancer Panels
Cancer panels use next generation sequencing (NGS) technology to target specific genes or mutations that have established relevancy to a particular cancer phenotype.
Cancer panels use next generation sequencing (NGS) technology to target specific genes or mutations that have established relevancy to a particular cancer phenotype.
Methylation sequencing is the process in which DNA methylation is quantified using sodium bisulfite and subsequent nucleotide base conversion. To uncover the methylome, GENEWIZ uses wet and dry lab solutions, including Methyl-Seq, for global whole genome and targeted 5-methylcytosine (5mC) detection.
GENEWIZ TargetGxOne™ custom gene panels provide targeted resequencing of any gene of interest via next generation sequencing (NGS).
GENEWIZ routinely sequences pre-made amplicons on Illumina platforms to answer a myriad of biological questions.
GENEWIZ offers ultra-deep, contiguous amplicon sequencing for sequences up to 10,000 bp.
Immune Profiling couples ultra-deep sequencing of V(D)J regions and customized bioinformatics to provide comprehensive characterization of the entire B-cell receptor (BCR) and T-cell receptor (TCR) repertoire.
Single-cell RNA-Seq (scRNA-Seq) provides transcriptional profiling of thousands of individual cells. As an early adopter of the 10x Genomics® Chromium™ and Illumina® NovaSeq™ 6000., GENEWIZ Multiomics & Synthesis Solutions from Azenta Life Sciences provides optimized scRNA-Seq workflows.